TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8147164

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel intracervical for Bishop score < 5
Number of subjects: 1472

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 vaginal tablets for Bishop score between 5 and 8
Number of subjects: 1472

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion for Bishop score > 8
Number of subjects: 1472

Group type: EXPERIMENTAL
Intervention: Continuation of induction
Number of subjects: 1472

Group type: EXPERIMENTAL
Intervention: Cervical condition appropriate method of induction
Number of subjects: 1472
Study: 3764227

Group type: EXPERIMENTAL
Intervention: New drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Old drug
Number of subjects: 0
Study: 30795760

Group type: EXPERIMENTAL
Intervention: Berlin questionnaire in group A (home-based sleep test)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Berlin questionnaire in group B (hospital-based polysomnography)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Berlin questionnaire compared to PSG
Number of subjects: 316

Group type: COMPARATOR
Intervention: Berlin questionnaire compared to Embletta PDS
Number of subjects: 316

Group type: COMPARATOR
Intervention: Area under the ROC curve based on PSG
Number of subjects: 316

Group type: COMPARATOR
Intervention: Area under the ROC curve based on home Embletta
Number of subjects: 316
Study: 28991766

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided catheterization
Number of subjects: 400

Group type: COMPARATOR
Intervention: Landmark method catheterization
Number of subjects: 400
Study: 25611582

Group type: EXPERIMENTAL
Intervention: Pre-bariatric surgery physical activity intervention (PAI)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard pre‐surgical care (SC)
Number of subjects: 75
Study: 25219986

Group type: EXPERIMENTAL
Intervention: 40 mg methylprednisolone acetate injected preoperatively into the masseter muscle
Number of subjects: 60

Group type: COMPARATOR
Intervention: 40 mg methylprednisolone acetate injected postoperatively into the masseter muscle
Number of subjects: 60
Study: 22964250

Group type: EXPERIMENTAL
Intervention: LFF571 single doses (25 mg, 100 mg, 400 mg, and 1,000 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: LFF571 multiple doses (25 mg, 100 mg, or 200 mg every 6 h for 10 days)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 19306963

Group type: EXPERIMENTAL
Intervention: Barusiban (0.3, 1, 3, or 10 mg)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 17344656

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No inhaled nitric oxide (no iNO)
Number of subjects: 60
Study: 15125004

Group type: EXPERIMENTAL
Intervention: Fuzzy merging method
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Wall-thickening analysis
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Combination of fuzzy merging and wall-thickening analysis
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Overall CAD scheme
Number of subjects: 82
Study: 11453312

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (0.8 mg m(‐2) day(‐1) for 1 month, then 0.4 mg m(‐2) day(‐1) for 3 months)
Number of subjects: 21
Study: 9744787

Group type: EXPERIMENTAL
Intervention: Laparoscopic colposuspension
Number of subjects: 1

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 1
Study: 8061853

Group type: EXPERIMENTAL
Intervention: Spirapril 6 mg/day
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Spirapril 12 mg/day
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Spirapril 24 mg/day
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Spirapril (all dosages)
Number of subjects: 260
Study: 3058383

Group type: EXPERIMENTAL
Intervention: Norinyl 1/35
Number of subjects: 300

Group type: COMPARATOR
Intervention: Brevicon
Number of subjects: 300
Study: 31680625

Group type: EXPERIMENTAL
Intervention: Promoting Resilience in Stress Management
Number of subjects: 92

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 92
Study: 30099030

Group type: EXPERIMENTAL
Intervention: Liraglutide treatment for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28891873

Group type: EXPERIMENTAL
Intervention: Stapedotomy with fixation of the incus‐prosthesis junction with glass ionomer bone cement (Group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Stapedotomy with the classic technique (Group A)
Number of subjects: 80
Study: 25887046

Group type: EXPERIMENTAL
Intervention: McKenzie method
Number of subjects: 350

Group type: COMPARATOR
Intervention: Spinal manipulation
Number of subjects: 350
Study: 24006669

Group type: EXPERIMENTAL
Intervention: Acupuncture group received acupuncture stimulation at various acupoints (Baihui, Neiguan, Sanyinjiao, Taichong, etc.) once daily, 5 times a week for 20 times.
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Catgut embedding group received catgut embedding at the same acupoints as the acupuncture group, once every 10 days, 3 times altogether.
Number of subjects: 63
Study: 21869695

Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg for 2 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 20
Study: 19153649

Group type: COMPARATOR
Intervention: Tau protein levels in AD patients
Number of subjects: 69

Group type: COMPARATOR
Intervention: Index tau/beta-amyloid(1-42) levels in AD patients
Number of subjects: 69

Group type: COMPARATOR
Intervention: Cystatin C values
Number of subjects: 69

Group type: COMPARATOR
Intervention: CSF cystatin C
Number of subjects: 69

Group type: COMPARATOR
Intervention: CSF tau protein
Number of subjects: 69
Study: 16384626

Group type: COMPARATOR
Intervention: -842C allele carriers in AD subjects
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: -842C allele
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: CC haplotype
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: -842 CC genotype or CC haplotype
Number of subjects: 111
Study: 15325930

Group type: EXPERIMENTAL
Intervention: Overt hyperthyroidism
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Subclinical hyperthyroidism (during antithyroid therapy)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Biochemical euthyroidism
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Antithyroid treatment
Number of subjects: 259

Group type: COMPARATOR
Intervention: Normal subjects with euthyroidism
Number of subjects: 259
Study: 15240983

Group type: EXPERIMENTAL
Intervention: 1,000 mg effervescent acetylsalicylic acid (ASA)
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: 50 mg encapsulated sumatriptan
Number of subjects: 433

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 433
Study: 10987048

Group type: EXPERIMENTAL
Intervention: Medico-surgical treatment (including nerve surgical decompression)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Medical treatment (steroids only)
Number of subjects: 31
Study: 7743399

Group type: EXPERIMENTAL
Intervention: Low-air-loss beds
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional foam mattresses
Number of subjects: 84
Study: 2073120

Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg daily for 14 days)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Clotrimazole troches (10 mg each, five troches daily for 14 days)
Number of subjects: 39
Study: 7027714

Group type: EXPERIMENTAL
Intervention: Oral glucose followed 60 min later by iv glipizide
Number of subjects: 6

Group type: COMPARATOR
Intervention: Iv glipizide followed 60 min later by oral glucose
Number of subjects: 6
Study: 31928269

Group type: EXPERIMENTAL
Intervention: Digital fetal scalp stimulation (dFSS)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Fetal blood sampling (FBS)
Number of subjects: 66
Study: 31708447

Group type: EXPERIMENTAL
Intervention: Support programme in addition to conventional care
Number of subjects: 2098

Group type: COMPARATOR
Intervention: Conventional care alone
Number of subjects: 2098
Study: 30226796

Group type: EXPERIMENTAL
Intervention: Extended-release carbidopa-levodopa (CD-LD) product
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate-release carbidopa-levodopa (CD-LD) product
Number of subjects: 0
Study: 29411721

Group type: EXPERIMENTAL
Intervention: Herbal tea mixture (stinging nettle) for 1 week
Number of subjects: 85

Group type: COMPARATOR
Intervention: Fruit tea (placebo) for 1 week
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (supportive measures only)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Serum prolactin levels measured at the beginning and on the seventh day
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Weight gain of preterm babies
Number of subjects: 85
Study: 26977864

Group type: EXPERIMENTAL
Intervention: Doppler‐assisted dearterialization of internal hemorrhoids with mucopexy (DDM)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Hemorrhoidectomy using harmonic scalpel (HE)
Number of subjects: 240
Study: 25169642

Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg single dose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 22896670

Group type: EXPERIMENTAL
Intervention: Statin-fenofibric acid therapy (FNA)
Number of subjects: 1865
Study: 20668372

Group type: EXPERIMENTAL
Intervention: 150 ml black tea extract (BTE) daily for weeks 1-4 (increasing to 600 ml by week 4)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 600 ml black tea extract (BTE) daily
Number of subjects: 46

Group type: COMPARATOR
Intervention: 150 ml black tea extract (BTE) daily (control group)
Number of subjects: 46
Study: 16822619

Group type: EXPERIMENTAL
Intervention: Internet-based self-assessment tool
Number of subjects: 343
Study: 15386785

Group type: EXPERIMENTAL
Intervention: Diet intervention with reduced intake of fat and increased intakes of fiber, calcium, and vegetables and fruit, with diet counseling provided by telephone.
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 77
Study: 11876809

Group type: EXPERIMENTAL
Intervention: Maternal falciparum malaria infection
Number of subjects: 995

Group type: EXPERIMENTAL
Intervention: Histological evidence of past placental malaria infection
Number of subjects: 995
Study: 10418851

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy of Metformin and Troglitazone
Number of subjects: 0
Study: 7587908

Group type: EXPERIMENTAL
Intervention: Multiple injection regimen of insulin therapy (Group II, n = 9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Maximal OAD (Group I, n = 9)
Number of subjects: 18
Study: 29101711

Group type: EXPERIMENTAL
Intervention: 15-week group-based weight loss intervention including caloric restriction and physical activity
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15-week group-based weight loss intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait-list control intervention
Number of subjects: 60
Study: 28876473

Group type: EXPERIMENTAL
Intervention: Intervention schools introducing recycled materials and risk-reframing workshops
Number of subjects: 226

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 226
Study: 25716487

Group type: EXPERIMENTAL
Intervention: Cannabis use disorder (CUD) group, N=21
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Non-CUD group, N=14
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: CUD group, N=21
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group, N=22
Number of subjects: 35
Study: 23685450

Group type: EXPERIMENTAL
Intervention: 6-week interactive, parent-based intervention
Number of subjects: 73

Group type: COMPARATOR
Intervention: General health condition (control)
Number of subjects: 73
Study: 22616205

Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of 8 weekly sessions with interactive materials, cooking demonstrations, and discussions on breast cancer prevention.
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of 8 weekly sessions.
Number of subjects: 119

Group type: COMPARATOR
Intervention: Written breast health educational materials.
Number of subjects: 119
Study: 19797937

Group type: EXPERIMENTAL
Intervention: 20 mg controlled-release oxycodone
Number of subjects: 54

Group type: COMPARATOR
Intervention: 200 mg controlled-release tramadol
Number of subjects: 54
Study: 17023289

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 320

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 320
Study: 15571784

Group type: EXPERIMENTAL
Intervention: DVPX+Risp
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Li+Risp
Number of subjects: 37
Study: 10898540

Group type: EXPERIMENTAL
Intervention: Docetaxel 60 mg/m2 followed by CPT‐11 190 mg/m2 on day 1, repeated every 3 weeks
Number of subjects: 15
Study: 9243561

Group type: EXPERIMENTAL
Intervention: Hair testing for drugs of abuse (cocaine and opiates)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hair testing for drugs of abuse
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Analysis of hair washes and nails from autopsy samples
Number of subjects: 100
Study: 8438659

Group type: EXPERIMENTAL
Intervention: Twice-weekly exercise
Number of subjects: 49

Group type: COMPARATOR
Intervention: Reminiscence sessions
Number of subjects: 49
Study: 3940518

Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral meclizine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31227386

Group type: EXPERIMENTAL
Intervention: Gender transformative life-skills education cum sports-coaching program for younger boys (aged 13-14 years)
Number of subjects: 962
Study: 31605442

Group type: COMPARATOR
Intervention: Antioxidants
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Curcumin (systemic form)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Curcumin (systemic and topical forms)
Number of subjects: 119
Study: 28468653

Group type: EXPERIMENTAL
Intervention: Low dose aspirin (81 mg) daily administration, initiated between 6 0/7 weeks and 13 6/7 weeks GA and continued to 36 0/7 weeks GA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (identical appearing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low dose aspirin (81 mg)
Number of subjects: 0
Study: 25246609

Group type: EXPERIMENTAL
Intervention: mCIMT combined with trunk restraint
Number of subjects: 18

Group type: COMPARATOR
Intervention: mCIMT
Number of subjects: 18
Study: 22751026

Group type: EXPERIMENTAL
Intervention: Analgesics after ED care
Number of subjects: 244
Study: 21802381

Group type: EXPERIMENTAL
Intervention: Lipiodol transarterial chemoembolisation with amiodarone and anthracycline (pirarubicin or doxorubicin)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Lipiodol transarterial chemoembolisation with anthracycline alone (control group)
Number of subjects: 27
Study: 18642348

Group type: EXPERIMENTAL
Intervention: Darbepoetin-alpha
Number of subjects: 1558
Study: 16801652

Group type: EXPERIMENTAL
Intervention: Elective stenting of symptomatic intracranial stenosis
Number of subjects: 169
Study: 14594779

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention group (dietary and antismoking advice)
Number of subjects: 1232

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1232
Study: 10764853

Group type: EXPERIMENTAL
Intervention: Laser-assisted in situ keratomileusis
Number of subjects: 13
Study: 9216145

Group type: EXPERIMENTAL
Intervention: Mechanical heart valve implantation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Native mitral or aortic valves
Number of subjects: 40
Study: 1598953

Group type: EXPERIMENTAL
Intervention: lodoxamide 0.1% ophthalmic solution
Number of subjects: 120

Group type: COMPARATOR
Intervention: cromolyn sodium 4% ophthalmic solution
Number of subjects: 120
Study: 4044294

Group type: EXPERIMENTAL
Intervention: 0.5 mg riboflavin supplementation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 1.0 mg riboflavin supplementation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 1.5 mg riboflavin supplementation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 2 mg riboflavin load
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no supplement)
Number of subjects: 36
Study: 29530035

Group type: EXPERIMENTAL
Intervention: Unified Protocol in group format
Number of subjects: 220

Group type: COMPARATOR
Intervention: Treatment as usual (individual cognitive behavioral therapy)
Number of subjects: 220
Study: 27436422

Group type: EXPERIMENTAL
Intervention: Measles Vaccine (MV)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Diphtheria-Tetanus-Pertussis (DTP)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Both MV and DTP administered together
Number of subjects: 302
Study: 26420196

Group type: EXPERIMENTAL
Intervention: Public dietitian-led intervention
Number of subjects: 117

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 117
Study: 24282383

Group type: EXPERIMENTAL
Intervention: Tai Chi Qigong (TCQ)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Exercise group (breathing and walking exercise)
Number of subjects: 206
Study: 21068672

Group type: EXPERIMENTAL
Intervention: Topically administered halofuginone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study: 18294487

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 2521

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 2521
Study: 16472338

Group type: EXPERIMENTAL
Intervention: Patients with CTTH
Number of subjects: 50

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 50
Study: 15709463

Group type: EXPERIMENTAL
Intervention: Triticum vulgaris (Fitostimoline)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study: 11213274

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (VIAGRA)
Number of subjects: 482

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 482
Study: 9446004

Group type: EXPERIMENTAL
Intervention: L-methionine (Acimethin) 3 x 1 tablet daily for 26 months
Number of subjects: 43

Group type: COMPARATOR
Intervention: Nalidixic acid (Nevigramon) 1 tablet 3 times daily for 21.6 months
Number of subjects: 43
Study: 7939490

Group type: EXPERIMENTAL
Intervention: Subjects under time pressure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subjects under no time pressure
Number of subjects: 0
Study: 2963213

Group type: EXPERIMENTAL
Intervention: Nafarelin (800 micrograms per day)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Nafarelin (400 micrograms per day)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Danazol (800 mg per day)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Nafarelin (both doses) and Danazol
Number of subjects: 213

Group type: COMPARATOR
Intervention: Nafarelin and Danazol
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Nafarelin
Number of subjects: 213
Study: 31771940

Group type: EXPERIMENTAL
Intervention: PEITC (10 mg in 1 mL of olive oil, 4 times per day)
Number of subjects: 79

Group type: COMPARATOR
Intervention: PEITC
Number of subjects: 79
Study: 29288162

Group type: EXPERIMENTAL
Intervention: Nasal high flow (nHF)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (CPAP)
Number of subjects: 429
Study: 27916036

Group type: COMPARATOR
Intervention: Patient Controlled Intravenous Analgesia (PCIA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patient Controlled Thoracic Paravertebral Block (PCPB)
Number of subjects: 60
Study: 24325649

Group type: EXPERIMENTAL
Intervention: Novel disposable sheathed gastroscope
Number of subjects: 1140

Group type: COMPARATOR
Intervention: Conventional gastroscope
Number of subjects: 1140
Study: 22728645

Group type: EXPERIMENTAL
Intervention: Approach Avoidance Task (AAT) designed to increase approach tendencies for positive social cues
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition with no contingency between arm movement direction and picture type
Number of subjects: 0
Study: 20386017

Group type: EXPERIMENTAL
Intervention: Sotrastaurin 400 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tacrolimus 7 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sotrastaurin 400 mg + Tacrolimus 7 mg
Number of subjects: 18
Study: 18175741

Group type: EXPERIMENTAL
Intervention: Fresh yogurt
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Heat-treated yogurt
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (no yogurt)
Number of subjects: 79
Study: 15753744

Group type: EXPERIMENTAL
Intervention: Decision support on (smart infusion pumps with integrated decision support software)
Number of subjects: 744

Group type: COMPARATOR
Intervention: Decision support off (control group)
Number of subjects: 744
Study: 14523142

Group type: EXPERIMENTAL
Intervention: 9-valent pneumococcal conjugate vaccine
Number of subjects: 39936
Study: 10590328

Group type: EXPERIMENTAL
Intervention: Combined vaccine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Simultaneous vaccination
Number of subjects: 150

Group type: COMPARATOR
Intervention: Single HAV vaccination
Number of subjects: 150

Group type: COMPARATOR
Intervention: Single HBV vaccination
Number of subjects: 150
Study: 9289454

Group type: EXPERIMENTAL
Intervention: Magnesium concentration in women with pregnancy threatening miscarriage
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Calcium concentration in women with pregnancy threatening miscarriage
Number of subjects: 75

Group type: COMPARATOR
Intervention: Magnesium concentration in normal uterine pregnancy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Calcium concentration in normal uterine pregnancy
Number of subjects: 75
Study: 2053669

Group type: EXPERIMENTAL
Intervention: Training about smoking cessation counseling with staff support and designated follow-up time
Number of subjects: 0

Group type: COMPARATOR
Intervention: Training about smoking cessation counseling
Number of subjects: 0
Study: 6389609

Group type: EXPERIMENTAL
Intervention: Topical application of citric acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 0